Jianjun Zou
210006, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to 'Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling' [Int. Immunopharmacol. 71 (2019) 144-154].
Journal: International immunopharmacology
Published: September 26, 2024
Retraction Note: SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 20, 2022
SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 13, 2020
Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Journal: Cell death and differentiation
Published: February 07, 2020
Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis.
Journal: Biochemical pharmacology
Published: September 16, 2019
Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Journal: Cell death and differentiation
Published: April 20, 2019
Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling.
Journal: International immunopharmacology
Published: December 24, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026